Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver Function
NCT00851227
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Liver Disease
Hyponatremia
Interventions
DRUG:
conivaptan hydrochloride
Sponsor
Cumberland Pharmaceuticals